LUSSO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 15.566
NA - Nord America 4.242
AS - Asia 1.366
SA - Sud America 186
AF - Africa 13
OC - Oceania 4
Totale 21.377
Nazione #
IT - Italia 14.657
US - Stati Uniti d'America 4.223
CN - Cina 586
SG - Singapore 559
UA - Ucraina 351
SE - Svezia 224
BR - Brasile 158
DE - Germania 90
GB - Regno Unito 84
FI - Finlandia 83
VN - Vietnam 47
IN - India 45
KR - Corea 38
FR - Francia 34
HK - Hong Kong 27
RU - Federazione Russa 21
BD - Bangladesh 14
TR - Turchia 12
AR - Argentina 11
CA - Canada 8
IQ - Iraq 8
MX - Messico 8
NL - Olanda 6
ID - Indonesia 5
AE - Emirati Arabi Uniti 4
AT - Austria 4
CO - Colombia 4
ES - Italia 4
PK - Pakistan 4
UZ - Uzbekistan 4
AU - Australia 3
EC - Ecuador 3
MU - Mauritius 3
VE - Venezuela 3
ZA - Sudafrica 3
CL - Cile 2
IL - Israele 2
JP - Giappone 2
LT - Lituania 2
MA - Marocco 2
NP - Nepal 2
PL - Polonia 2
SA - Arabia Saudita 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GT - Guatemala 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TT - Trinidad e Tobago 1
Totale 21.377
Città #
Cagliari 14.334
Woodbridge 537
Fairfield 534
Houston 343
Chandler 315
Singapore 298
Ashburn 281
Seattle 243
Ann Arbor 224
Cambridge 203
Wilmington 196
Boardman 193
Jacksonville 189
Dallas 156
Nyköping 153
Uta 143
Beijing 130
Hefei 75
Los Angeles 74
Santa Clara 62
Boston 56
Buffalo 55
Nanjing 50
San Diego 43
Seoul 36
Shanghai 33
Milan 31
Verona 29
Hong Kong 27
Pune 27
Helsinki 24
Hebei 22
Nanchang 22
Jiaxing 20
Changsha 17
Jinan 16
Shenyang 16
Munich 15
Tianjin 15
Sassari 14
The Dalles 14
Ho Chi Minh City 11
New York 11
Guangzhou 10
Frankfurt am Main 9
Hanoi 9
London 9
Norwalk 8
São Paulo 8
Zhengzhou 7
Belo Horizonte 6
Council Bluffs 6
Haiphong 6
Mountain View 6
Ningbo 6
Orange 6
Brooklyn 5
Chicago 5
Nuremberg 5
Saint Petersburg 5
San Jose 5
Atlanta 4
Columbus 4
Delhi 4
Dhaka 4
Goiânia 4
Redwood City 4
Salt Lake City 4
Taizhou 4
Washington 4
Bangalore 3
Dearborn 3
Düsseldorf 3
Erbil 3
Kunming 3
Paris 3
Porto Alegre 3
Portsmouth 3
Rome 3
Salvador 3
San Francisco 3
Stockholm 3
Tashkent 3
Tonara 3
Toronto 3
Turku 3
Antalya 2
Baghdad 2
Campinas 2
Castellammare di Stabia 2
Cedar Knolls 2
Chennai 2
Contagem 2
Curitiba 2
Denver 2
Elk Grove Village 2
Fresno 2
Gallatin 2
Hangzhou 2
Hounslow 2
Totale 19.520
Nome #
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 1.658
Calibration Technologies for Correct Determination of Epstein-Barr Virus, Human Herpesvirus 6 (HHV-6), and HHV-8 Antiviral Drug Susceptibilities by Use of Real-Time-PCR-Based Assays 586
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor 566
Chromosomally integrated human herpesvirus 6: questions and answers 565
Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections 554
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity 552
Enhancement of Anti-HIV-1 Activity by Hot Spot Evolution of RANTES-Derived Peptides 547
Development of a Human Herpesvirus 6 Species-Specific Immunoblotting Assay 533
Classification of HHV-6A and HHV-6B as distinct viruses 528
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses 525
Selective Reactivation of Human Herpesvirus 6 in Patients With Autoimmune Connective Tissue Diseases 521
Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples 495
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 482
Treatment with IL-7 Prevents the Decline of Circulating CD4(+) T Cells during the Acute Phase of SIV Infection in Rhesus Macaques 480
HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis 472
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4(pos) T cells and macrophages 466
Protein-based HIV-1 microbicides. 464
lmmunomodulation and immunosuppression by human herpesvirus 6A and 6B 461
Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability 460
IL-7 induces expression and activation of integrin alpha 4 beta 7 promoting naive T-cell homing to the intestinal mucosa 410
Inhibition of HIV-1 Infection by Human alpha-Defensin-5, a Natural Antimicrobial Peptide Expressed in the Genital and Intestinal Mucosae 401
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants 352
Human herpesvirus 6A accelerates AIDS progression in macaques 348
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT 337
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A 327
Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases 318
Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages 318
Clinical significance of HIV-1 coreceptor usage 313
A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2 309
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers 304
Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection 304
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity 303
A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load 303
International network for comparison of HIV neutralization assays: the NeutNet report 298
Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer 297
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein 297
Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4 295
Rational design of novel HIV-1 entry inhibitors by RANTES engineering 293
Identification of RANTES MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells 276
HHV-6 and CMV pneumonitis in immunocompromised patients 272
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains 264
Infection of natural killer cells by human herpesvirus 6 253
Selective suppression of IL-12 production by human herpesvirus 6 247
: Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4 244
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 243
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection 242
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals 242
HHV-6 and the immune system: mechanisms of immunomodulation and viral escape 240
CD46 is a cellular receptor for human herpesvirus 6 234
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression 225
HIV and the chemokine system 224
Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation 222
Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6 208
A rationally designed CD4 mimic inhibits HIV-1 entry and exposes cryptic neutralization epitopes 203
HIV and chemokines: Implications for therapy and vaccines 184
Structural determinants of HIV-1 blockade and CCR5 recognition in RANTES 181
Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity 177
Totale 21.423
Categoria #
all - tutte 43.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.116


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.356 0 0 0 0 0 466 312 213 47 126 122 70
2021/2022652 49 121 39 19 36 15 44 29 64 42 94 100
2022/20231.191 130 115 112 97 101 175 46 127 126 37 55 70
2023/20241.601 120 47 72 172 143 143 86 110 82 329 131 166
2024/20251.476 101 101 243 93 160 129 88 60 125 95 131 150
2025/20261.094 148 135 342 148 147 174 0 0 0 0 0 0
Totale 21.423